Determining therapeutic susceptibility in multiple myeloma by single-cell mass accumulation
Multiple myeloma (MM) has benefited from significant advancements in treatment that have improved outcomes and reduced morbidity. However, the disease remains incurable and is characterized by high rates of drug resistance and relapse. Consequently, methods to select the most efficacious therapy are...
Main Authors: | Cetin, Arif Engin (Contributor), Stevens, Mark M. (Contributor), Calistri, Nicholas L (Contributor), Olcum, Selim A. (Contributor), Kimmerling, Robert John (Contributor), Manalis, Scott R (Contributor) |
---|---|
Other Authors: | Massachusetts Institute of Technology. Department of Biological Engineering (Contributor), Massachusetts Institute of Technology. Department of Mechanical Engineering (Contributor), Koch Institute for Integrative Cancer Research at MIT (Contributor) |
Format: | Article |
Language: | English |
Published: |
Nature Publishing Group,
2017-11-28T20:49:38Z.
|
Subjects: | |
Online Access: | Get fulltext |
Similar Items
-
Determining therapeutic susceptibility in multiple myeloma by single-cell mass accumulation
by: Arif E. Cetin, et al.
Published: (2017-11-01) -
Precision mass measurements in solution reveal properties of single cells and bioparticles
by: Olcum, Selim A., et al.
Published: (2017) -
Microfluidic active loading of single cells enables analysis of complex clinical specimens
by: Nicholas L. Calistri, et al.
Published: (2018-11-01) -
Drug sensitivity of single cancer cells is predicted by changes in mass accumulation rate
by: Maire, Cecile L, et al.
Published: (2017) -
Microfluidic active loading of single cells enables analysis of complex clinical specimens
by: Malinowski, Seth W., et al.
Published: (2019)